Patents by Inventor Jacques Benveniste

Jacques Benveniste has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9421225
    Abstract: The invention concerns a method and a system for producing a signal, in particular an electric signal, or a substance having a coagulating or anticoagulant effect. The method is characterized in that it is based on a source substance with coagulating effect, in particular, Ca++ ions, or an anticoagulant affect, in particular heparin. The method consists in: transforming the electromagnetic field derived from said source substance located in the chamber, into a signal, in particular an electric signal, using a transducer-receiver sensing the electromagnetic field; applying to a receiving substance located in the chamber, in particular water or a water-ethanol mixture or homeopathic granules, said signal derived from said transducer-receiver, using a transducer-transmitter. After said treatment, the receiving substance, initially inactive, has a coagulating or anticoagulant effect.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: August 23, 2016
    Assignee: DiGiBio
    Inventors: Jacques Benveniste, Didier Guillonnet
  • Publication number: 20100272629
    Abstract: The invention relates to a method and a system for giving a substance (101) receptive and/or transmissive properties that allow the substance (101) to be treated by and/or to transmit a signal acquired by intercepting an electromagnetic field originating from a source substance. The substance (101) is subjected, by means of a transmitter (102), to an electromagnetic field and/or a sound (104) emitted at one or more frequencies included in a predetermined frequency spectrum for a predetermined period. The invention makes it possible to give the initially non-receptive and non-transmissive substance (101)y receptive and/or transmissive properties.
    Type: Application
    Filed: June 1, 2005
    Publication date: October 28, 2010
    Applicant: DIGIBIO SA
    Inventors: Jacques Benveniste, Jerome Benveniste, Vincent Benveniste, Laurent Benveniste, Claire Benveniste, Alice Benveniste
  • Publication number: 20100233296
    Abstract: The invention concerns a method and a system for producing a signal, in particular an electric signal, or a substance having a coagulating or anticoagulant effect. The method is characterised in that it is based on a source substance with coagulating effect, in particular, Ca++ ions, or an anticoagulant affect, in particular heparin. The method consists in: transforming the electromagnetic field derived from said source substance located in the chamber, into a signal, in particular an electric signal, using a transducer-receiver sensing the electromagnetic field; applying to a receiving substance located in the chamber, in particular water or a water-ethanol mixture or homeopathic granules, said signal derived from said transducer-receiver, using a transducer-transmitter. After said treatment, the receiving substance, initially inactive, has a coagulating or anticoagulant effect.
    Type: Application
    Filed: December 8, 2009
    Publication date: September 16, 2010
    Applicant: DigiBio
    Inventors: Jacques Benveniste, Laurent Benveniste, Didier Guillonnet
  • Publication number: 20070172898
    Abstract: A method of diagnosing intolerance by a subject to a specified substance which comprises incubating a leucocyte sample prepared from whole blood drawn from the subject with an extract of said substance and detecting whether or not PMNs in the sample have become activated.
    Type: Application
    Filed: July 2, 2004
    Publication date: July 26, 2007
    Inventor: Jacques Benveniste
  • Publication number: 20040038937
    Abstract: The invention concerns a method applied to a substance treated to exhibit a biological activity, for example a coagulating or anticoagulation activity. The treated substance has been obtained from a source substance having the biological activity, after a treatment such that the treated substance does not contain any molecule of the source substance in significant amount. The treatment can in particular consist in using a high dilution process of the same type used for producing homeopathic solutions or granules. The method is designed to protect the treated substance from external factors to which it is subjected and is characterised in that it comprises the step which consists in placing the treated substance in a chamber (19), sheltered from electromagnetic fields. The chamber (19) is enclosed with a magnetic shield (19a) made in particular of soft iron or mumetal.
    Type: Application
    Filed: August 25, 2003
    Publication date: February 26, 2004
    Inventors: Jacques Benveniste, Didier Guillonnet
  • Patent number: 6541978
    Abstract: The invention concerns a method, a system and a device for producing, from a substance, electric signals characteristic of the biological activity of an active element contained in the substance. The method consists in: placing the substance in a zone subjected to a specific electric, magnetic and/or electromagnetic excitation field. The method further includes a step which consists in transforming the fields resulting form the interaction between the specific excitation filed and the substance, into signals, in particular electric signals, using a first transducer receiving the resulting fields.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: April 1, 2003
    Assignee: Digibio
    Inventors: Jacques Benveniste, Didier Guillonnet